Weber T K, Conlon W, Petrelli N J, Rodriguez-Bigas M, Keitz B, Pazik J, Farrell C, O'Malley L, Oshalim M, Abdo M, Anderson G, Stoler D, Yandell D
Department of Surgery, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Cancer Res. 1997 Sep 1;57(17):3798-803.
Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant cancer syndrome characterized by early age of onset colorectal cancer (mean 45 years) as well as endometrial, urinary tract, and upper gastrointestinal adenocarcinomas. The HNPCC phenotype has been shown to segregate with germline mutations in the human homologues of the DNA mismatch repair genes MSH2, MLH1, PMS1, and PMS2. However, the majority of published DNA mismatch repair gene mutation surveys associated with HNPCC kindreds report multiple levels of preselection, including 2p and 3p chromosomal linkage analysis and the evaluation of microsatellite instability of proband colorectal cancers prior to mutation analysis. For this reason, the concise contribution of each of the known DNA mismatch repair genes to the HNPCC phenotype remains unknown. We report the results of a genomic DNA-based analysis of hMSH2 and hMLH1 germline mutations in 32 unrelated Eastern United States HNPCC kindreds. These families were selected for study on the basis of phenotype only. We identified three hMSH2 and six hMLH1 mutations in eight families, for a positive mutation rate of 25%. Two mutations were identified in one of the families. Four of the mutations detected have not been reported in the literature previously. One of the mutation-positive families is African American; the others were of European-American ancestry. These results provide a clarification of the contribution of hMSH2 and hMLH1 to the HNPCC phenotype and suggest that in the majority of Eastern United States HNPCC kindreds selected by phenotype alone, the molecular genetic basis for the disease remains unknown.
遗传性非息肉病性结直肠癌(HNPCC)是一种常染色体显性癌症综合征,其特征为结直肠癌发病年龄较早(平均45岁),同时伴有子宫内膜癌、泌尿系统癌和上消化道腺癌。研究表明,HNPCC表型与DNA错配修复基因MSH2、MLH1、PMS1和PMS2的人类同源基因中的种系突变相关。然而,大多数已发表的与HNPCC家族相关的DNA错配修复基因突变调查都报告了多个层面的预选,包括2号和3号染色体连锁分析以及在突变分析之前对先证者结直肠癌的微卫星不稳定性进行评估。因此,每个已知的DNA错配修复基因对HNPCC表型的确切贡献仍然未知。我们报告了对美国东部32个无亲缘关系的HNPCC家族进行的基于基因组DNA的hMSH2和hMLH1种系突变分析结果。这些家族仅根据表型进行选择研究。我们在8个家族中鉴定出3个hMSH2突变和6个hMLH1突变,阳性突变率为25%。在其中一个家族中鉴定出两个突变。检测到的4个突变此前未在文献中报道。其中一个突变阳性家族是非裔美国人;其他家族为欧裔美国人。这些结果澄清了hMSH2和hMLH1对HNPCC表型的贡献,并表明在仅根据表型选择的美国东部大多数HNPCC家族中,该疾病的分子遗传基础仍然未知。